BT Lab
SKU:BT-AP09704
GPVI Polyclonal Antibody
GPVI Polyclonal Antibody
Couldn't load pickup availability
This gene encodes a platelet membrane glycoprotein of the immunoglobulin superfamily. The encoded protein is a receptor for collagen and plays a critical role in collagen-induced platelet aggregation and thrombus formation. The encoded protein forms a complex with the Fc receptor gamma-chain that initiates the platelet activation signaling cascade upon collagen binding. Mutations in this gene are a cause of platelet-type bleeding disorder-11 (BDPLT11). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
The GPVI Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of GPVI protein expression in various biological samples. This antibody has been extensively validated and exhibits exceptional sensitivity and specificity, making it an ideal choice for researchers in the field of immunology and molecular biology.
The GPVI Polyclonal Antibody is produced using state-of-the-art techniques, ensuring a high affinity and low background signal. It has been rigorously tested against a wide range of species, including human, mouse, and rat, guaranteeing its versatility and applicability in diverse experimental settings.
This antibody is supplied as a liquid formulation, allowing for easy and convenient handling. It is provided in a ready-to-use format, eliminating the need for time-consuming and complex preparation steps. The GPVI Polyclonal Antibody is compatible with various immunological techniques, including Western blotting, immunohistochemistry, and flow cytometry, enabling comprehensive analysis of GPVI protein expression and localization.
With its exceptional performance characteristics and broad compatibility, the GPVI Polyclonal Antibody is an indispensable tool for researchers investigating GPVI-related processes and diseases. Its reliable and reproducible results will contribute to a deeper understanding of GPVI function and pave the way for the development of novel therapeutic strategies targeting this protein.
Share
